Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking semaglutide after eating significantly reduces how much of the medicine your body absorbs, which matters far more for the tablet form than for the weekly injection. For the Wegovy injection, food timing has no meaningful effect on absorption at all. For Wegovy tablets, the guidance is strict: take it first thing in the morning on an empty stomach, then wait at least 30 minutes before eating, drinking anything other than plain water, or swallowing other medicines. Both forms of semaglutide are prescription-only medicines, and a prescriber will explain the right routine for your specific treatment during your clinical assessment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide comes in two licensed UK forms for weight management: the once-weekly Wegovy injection and, as of June 2026, the once-daily Wegovy tablet. The question of food timing almost entirely concerns the tablet.
The injection is delivered directly under the skin, so it bypasses the gut entirely. Absorption happens through subcutaneous tissue regardless of whether you've just eaten or fasted overnight. NHS guidance on weight-management injections confirms there are no food restrictions around the time of the Wegovy jab, morning, evening, before dinner or after it, the choice is yours, as long as you keep to the same day each week.
The tablet is a different matter. Oral semaglutide uses an absorption enhancer called SNAC to help the medicine cross the stomach lining before food dilutes it. That window is short and sensitive. Eat or drink anything other than a few sips of plain water before your 30 minutes are up, and a meaningful portion of the dose simply won't reach your bloodstream. There is more detail on exactly how the injection's timing flexibility works if you want to compare the two side by side.
The licensed routine for Wegovy tablets is straightforward, but it does require a small adjustment to your morning. When you wake, before the kettle goes on and before breakfast, swallow the tablet whole with no more than around 120 ml of plain water. Set a timer. For the next 30 minutes, nothing else passes your lips, not coffee, not juice, not another tablet. After those 30 minutes, eat and drink as normal.
The reason the guidance specifies plain water rather than any other liquid is that even drinks containing small amounts of dissolved substances can interfere with SNAC's action in the stomach lining. The MHRA-approved Wegovy tablet schedule starts at 1.5 mg and is titrated through 4 mg and 9 mg to a 25 mg maintenance dose, with at least a month at each stage. That escalation is designed to give your digestive system time to settle, gastrointestinal side effects are the most commonly reported, affecting the majority of participants in the OASIS 4 trial, though most were mild and eased over time.
No refrigeration is needed for the tablet, which makes it genuinely travel-friendly: a packet sits in a handbag or bedside drawer without any cold-chain requirement that the injection demands.
Missing the fasted window occasionally is not a crisis, but it is worth understanding what happens. Studies on oral semaglutide consistently show that food (particularly a high-fat meal) reduces peak plasma concentration significantly. Taking the tablet after breakfast does not produce a dangerous event; it simply means that dose is likely less effective than it would have been taken fasted.
The practical guidance from the patient information leaflet (the most authoritative source for your specific product) is to skip that day's tablet if you have already eaten and wait until the next morning rather than trying to compensate later in the day. Doubling up is not recommended. If you find the fasted routine consistently difficult to follow, that is a conversation worth having with your prescriber, it may affect which form of semaglutide suits you best, and some people find the weekly injection simpler to fit around their life, particularly if they have questions such as whether semaglutide can still be used after 28 days. You can read about broader eligibility considerations for semaglutide treatment to understand the full clinical picture.
For anyone wondering about the injection's flexibility around scheduling days, there is separate guidance on adjusting the day of your weekly dose, again, a question for your prescriber and the patient leaflet first.
Both forms of semaglutide are licensed for adults with a BMI of 30 or above, or 27 and above alongside at least one weight-related condition such as high blood pressure, raised cholesterol or obstructive sleep apnoea. Understanding the BMI criteria that apply to semaglutide is useful before starting, because eligibility shapes which treatment a prescriber is likely to recommend.
Longer term, the routine that matters most is the one you actually stick to. For the tablet, that means genuinely building the 30-minute fasted window into your morning, it becomes habit quickly for most people. For the injection, consistency means choosing the same day each week and storing your pen correctly in the fridge, with refrigeration required between 2 °C and 8 °C (the patient information leaflet gives the exact room-temperature window if you need it for travel).
The NHS medicines page for semaglutide covers practical storage and administration detail at a level you can act on, and it is worth bookmarking alongside your patient information leaflet. If you are considering treatment and want to understand the cost side, our guide to Wegovy pricing in the UK explains what a legitimate private prescription includes. When you are ready to explore whether semaglutide is clinically suitable for you, starting a free consultation is the first step, a GPhC-registered prescriber, not an algorithm, reads your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.